Ted represents public companies, private companies, and banks in connection with securities law and general corporate matters. He has closed hundreds of corporate and capital markets transactions, representing issuers across a wide variety of industries, including life sciences, energy and renewables, consumer products, technology, medical device, last-mile service and logistics, CBD health and wellness, and others, and has represented boutique investment banks through bulge brackets as underwriter or placement agent.
Ted has represented Nasdaq-, OTC-, and CSE-listed companies in their public offerings, private placements, contracts and agreements and SEC filings, as well as having served as their outside General Counsel. He also assists Australian and Canadian Companies on U.S. related matters, including acting as outside general counsel, providing corporate governance advice, contractual matters, intellectual property filings, FDA submissions, financings, securities offerings and listings, and currently represent certain U.S. based underwriters on their cross-border offerings and listings involving Australian and Canadian issuers.
In addition to his securities work, Ted’s company clients trust him to staff and oversee a broad variety of matters related to intellectual property, licensing, litigation and white-collar, realty, trust and estate, and other issues. His clients know that he will stay involved while always maintaining an efficient, responsive, and cost-conscious approach to any matter entrusted to him.
In addition, Ted has provided pro bono services representing clients in healthcare, Catholic school education, the Holocaust Project, and the arts.
Selected Public Company Representations
- Representation of a public company in a $2.375M private placement of convertible debt of a dual-listed U.S. and Canadian logistics company.
- Representation of a dual-listed company in connection with its establishment of an equity line of credit facility, including preparation of registration statement, and filing with and clearance by the SEC.
- Representation of a public company client in connection with a shareholder meeting via proxy, including Charter amendment and board elections.
- Representation of a public company in a debt offering, convertible into up to 5 million shares of common stock.
- Representation of a publicly traded Canadian company in its cash and stock acquisition of a multimillion-dollar U.S.-based logistics and last mile delivery business, including regulatory analysis and clearance, as well as on its simultaneous acquisition financing transaction.
- Bridge financing for a publicly listed company in the form of a convertible debenture with an institutional fund.
- Representation of Integrated Media Technology Corp., a Nasdaq-listed Australian company, in connection with a follow-on registered direct offering pursuant to a Securities Purchase Agreement with an accredited investor for the issuance and sale in a registered direct offering of 158,730 ordinary shares of the Company.
- Representation of a public company in connection with the preparation of a distribution agreement with a major northeast regional distributor who will be a reseller of our clients’ products, CBD and CBG infused edibles.
- Representation of an Australian public corporation in the preparation and filing of a Form S-8 registration statement and in connection with corporate governance issues.
- Representation of a US public company in the execution of a $5 million registered equity line of credit arrangement and filed and received effectiveness under Form S-1 pursuant to the terms of an Investment Agreement and Registration Rights Agreement with an institutional investor.
- Representation of Spherix Incorporated, a Nasdaq-listed company, in connection with its issuance of common stock, preferred stock and warrants in a Form S-1 offering.
- Representation of Spherix Incorporated in its licensing transaction with RPX Corporation (also a public company), whereby our client granted a license to RPX in exchange for the redemption of certain outstanding preferred stock, a release of liens on its assets and cash to our client, among other items included in the transaction.
- Representation of Spherix Incorporated, as issuer’s counsel, for aggregate financings of approximately $22 million via registered securities offerings of common stock and common stock warrants.
- Representation of PhotoMedex, Inc., as issuer’s counsel, for its $40 million concurrent registered offerings of common stock.
- Advised on a unit securities offering, consisting of common stock and warrants for a publicly traded and dual listed Canadian and US company client.
- Assisting Australian public company with ATM transaction as issuers counsel involving Cantor Fitzgerald as placement agent.
Selected Private Company Representations
Mr. Ghorra acts as outside general counsel to a number of private companies, assisting them on an ongoing basis with routine and event-driven securities filings, regulatory and compliance advice, licensing, mergers and acquisitions, and other matters.
- Assists various industry clients, including life science, medical device, and other industry-related companies in their financing, securities offerings, and fundraising transactions.
- Representing Australian dairy company in connection with various US matters, including establishment of US based subsidiary, proposed financings, FDA submissions, and various contractual matters.
- Representation of a medical device and biotechnology company in connection with a convertible note financing with a large pharma strategic fund.
- Representation of a medical device and biotechnology company in connection with development and collaboration agreements with global manufacturing and pharma companies.
- Representations of a Fintech Company in connection with regulatory and compliance matters involving their derivative trading and software technology, as well as registration matters.
- Representation of Lupagen Inc., a medical device company, in connection with a Services and Licensing Agreement with a major pharmaceutical company.
- Assisting a medical device/biotech client in the negotiation and preparation of a collaboration agreement with Umoja BioPharma Inc., including non-dilutive financing.
- Representation of a biotech client in the preparation of an employment agreement and executive compensation related matters.
- Representation of Serendipity Brands Inc., an ice cream manufacturing and distribution business, in connection with its private placement of securities.
- Representation of a U.S. private company in preparation of a Form 10 Registration Statement in its conversion to a publicly reporting company.
- Representation of a medical device company in connection with its licensing and domestic and international intellectual property matters, including patent and trademarks.
- Representation of a domestic consumer products company from formation, assisting the company from the product concept stage through IP securitization and product launch.
- Representation of a domestic company in its formation, establishment of online distribution, marketing and consulting arrangements and corporate governance advice, as well as in closing its initial financing transaction.
- Advised on a $2.5 million convertible debt financing for a medical device/biotechnology (privately held) company client with a large Japanese pharma company investor.
Selected Bank and Investment Fund Representations
- Secure FINRA and Nasdaq clearance for all transactions requiring regulatory submission and approval of such securities offerings.
- Representation of Alere Financial Partners, a division of Cova Capital Partners, as placement agent’s counsel in connection with private placement of common stock by NexGel, Inc.
- Representation of Wells Fargo Securities as lead underwriter in an underwritten offering of common stock by Avid Bioservices, Inc.
- Representation of Ambria Capital in connection with its investments in private and public companies, as well as in going public transactions.
- Representation of Needham & Company, LLC, as underwriter’s counsel, for Nova Measuring Instruments Ltd.’s (Israel domestic) $18.4 million CMPO offering of ordinary shares.
- Representation of Tangiers Capital in connection with securities law advice.
- Representation of Cowen Inc. as the exclusive Placement Agent for The Wet Seal, Inc.’s $27 million follow-on Regulation D Private Placement of public company securities.
- Representation of J.P. Morgan Securities, as underwriter’s counsel, in ARIAD Pharmaceuticals, Inc.’s $323 million public offering of common stock for newly FDA approved oncology therapy.
- Representation of Janney Montgomery Scott, as underwriter’s counsel, for d’ELia’s Inc.’s $15.8 million public offering of common stock, and a concurrent private placement of $21.8 million in principal amount of 7.25% convertible notes.
- Representation of Lazard Capital Markets LLC, Oppenheimer & Co. Inc., JMP Securities LLC and Maxim Group LLC, as underwriter’s counsel, for Organovo Holdings, Inc.’s $47 million public offering of common stock with over-allotment.
- Representation of Needham & Company, LLC and D.A. Davidson & Co. as underwriter’s counsel, for Radisys Corporation’s $23 million follow-on public offering of common stock.
- Representation of Lazard Capital Markets LLC, Cowen and Company LLC, JMP Securities LLC, Wedbush PacGrow Life Sciences and Canaccord Genuity, as underwriter’s counsel, for Sarepta Therapeutics, Inc.’s $125 million public offering of common stock.
- Representation of Lazard Capital Markets LLC, as underwriter’s counsel, for Globalstar Inc.’s $38 million private placement of convertible senior unsecured notes and warrants to purchase common stock.
- Representation of Barclays Capital, Inc., as underwriters’ counsel, for Halozyme Therapeutics, Inc.’s $72 million public offering of common stock.
- Representation of Lazard Capital Markets LLC, as placement agent’s counsel, for Evergreen Energy Inc.’s at-the-market program to sell up to $10 million in common stock.
- Representation of Kinderhook Partners L.P., as investor counsel, for Patient Safety Technologies, Inc.’s $7.1 million offering of common stock.
- Representation of Lazard Capital Markets LLC, as underwriter’s counsel, for Harvest Natural Resources Inc.’s $32 million registered direct offering of senior convertible notes.
- Roth Capital Partners in connection with US IPO of Australian public company.
News, Events, & Insights
- U.S. Law Guide for U.S. Companies on ASX
Insights August 7, 2023
- Tauriga Sciences, Inc. announces signing of major distribution agreement with online grocer and wholesaler, Stock Up Express
News January 26, 2021
- Rimon Law Welcomes Seasoned Transactional Lawyer Theodore Ghorra as Partner in its New York Office
News September 4, 2018